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ABSTRACT
Site-specifically modified 2’-methylseleno RNA
represents a valuable derivative for phasing of
X-ray crystallographic data. Several successful
applications in three-dimensional structure deter-
mination of nucleic acids, such as the Diels–Alder
ribozyme, have relied on this modification. Here, we
introduce synthetic routes to 2’-methylseleno phos-
phoramidite building blocks of all four standard
nucleosides, adenosine, cytidine, guanosine and
uridine, that are tailored for 2’-O-bis(acetoxy-
ethoxy)methyl (ACE) RNA solid-phase synthesis.
We additionally report on their incorporation into
oligoribonucleotides including deprotection and
purification. The methodological expansion of
2’-methylseleno labeling via ACE RNA chemistry is
a major step to make Se-RNA generally accessible
and to receive broad dissemination of the
Se-approach for crystallographic studies on RNA.
Thus far, preparation of 2’-methylseleno-modified
oligoribonucleotides has been restricted to
the 2’-O-[(triisopropylsilyl)oxy]methyl (TOM) and
2’-O-tert-butyldimethylsilyl (TBDMS) RNA synthesis
methods.
INTRODUCTION
Selenium-labeled oligonucleotides have become recog-
nized to represent useful derivatives for phasing of X-ray
crystallographic data in nucleic acid structure analysis.
Among various potential sites for modiﬁcation with
selenium, ribose 20-methylseleno groups have attracted
most attention so far. Since the pioneering work by Egli,
Huang and coworkers, which led to successful multi-
wavelength anomalous dispersion (MAD)-phasing of an
A-form DNA duplex via 20-methylseleno uridine (1–3),
our laboratory elaborated advanced procedures for the
preparation of 20-methylseleno-modiﬁed RNA, site-
speciﬁcally labeled at any of the four standard nucleosides,
adenosine, cytidine, guanosine and uridine (Figure 1)
(4–7). Thereby, the method we used for oligonucleotide
synthesis relied on nucleoside phosphoramidites protected
with the 20-O-[(triisopropylsilyl)oxy]methyl (TOM) pro-
tecting group (TOM chemistry) (8–13). Importantly, the
application of threo-1,4-dimercapto-2,3-butanediol (DTT)
during all steps of RNA preparation, including the solid-
phase synthesis cycle, was a major breakthrough for the
high performance of the Se-approach (5). This resulted in
the preparation of highly pure 20-methylseleno modiﬁed
RNAs with up to a hundred nucleotides, exempliﬁed by
the aptamer domain of the adenine riboswitch (5,14).
Successful applications of the Se-derivatized RNAs in
X-ray structure determination refer to the group I intron
(15), to the Diels–Alder ribozyme (16), to a short RNA
duplex that has been studied in context with the impact of
20-methylseleno groups on crystallization behavior and
crystal packing (7), and very recently, to HIV-1 genomic
RNA dimerization initiation site (DIS) constructs bound
to aminoglycoside antibiotics (17,18).
In the present work, we report on preparation of
oligoribonucleotides with site-speciﬁc 20-methylseleno
groups based on the 20-O-bis(acetoxyethoxy)methyl
(ACE) RNA solid-phase synthesis method. Nucleoside
phosphoramidites providing a ﬂuorine-labile silyl protec-
ting group at the ribose 50-OH and the acid-labile
orthoester protecting group at the ribose 20-OH were
introduced for chemical RNA synthesis in the late nineties
(19). Within a very short time, this innovative strategy
turned out to be highly competitive to commonly used
RNA synthesis methods based on 50-O 4,40-dimethoxy-
tritylated (DMT) nucleoside building blocks and laid the
basis for one of the largest custom RNA synthesis services
today. In particular, the very good quality of ACE
oligoribonucleotides that are commercially available con-
tributed to the high reputation of the method. In research
laboratories, usage of the ACE RNA approach has been
limited (20–22) and is generally considered complex
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zation period, and not least because of high costs when
compared to the 50-O-DMT methods. Under the aspect
that our previously established concept of selenium-
modiﬁed RNA for X-ray structure analysis would strongly
beneﬁt from compatibility with high-quality ACE RNA
synthesis, we put great eﬀorts into the adaptation of this
approach for the preparation of 20-methylseleno contain-
ing oligoribonucleotides. We show here that such deriva-
tives are readily available via the novel nucleoside
phosphoramidite building blocks and ACE RNA solid-
phase synthesis procedures outlined subsequently.
MATERIALS AND METHODS
Synthesis of2’-methylseleno modified nucleosides for
ACE RNA synthesis
General.
1H,
13C and
31P NMR spectra were recorded on
a Bruker DRX 300MHz, or Varian Unity 500MHz
instrument. The chemical shifts are reported relative to
TMS and referenced to the residual proton signal of the
deuterated solvents: CDCl3 (7.26p.p.m.), d6-DMSO
(2.49p.p.m.) for
1H-NMR spectra; CDCl3 (77.0p.p.m.)
or d6-DMSO (39.5p.p.m.) for
13C-NMR spectra.
31P-shifts are relative to external 85% phosphoric acid.
1H- and
13C-assignments were based on COSY and HSQC
experiments. UV-spectra were recorded on a Varian Cary
100 spectrophotometer. Analytical thin-layer chromatog-
raphy (TLC) was carried out on silica 60F-254 plates.
Flash column chromatography was carried out on silica
gel 60 (230–400 mesh or 70–230 mesh). All reactions were
carried out under argon atmosphere. Chemical reagents
and solvents were purchased from commercial suppliers
and used without further puriﬁcation. Benzhydryloxy-
bis(trimethylsilyloxy)chlorosilane (BzHCl) was obtained
from Dharmacon. Organic solvents for reactions
were dried overnight over freshly activated molecular
sieves (4A ˚ ).
Synthesis of 2’-methylseleno adenosinephosphoramidite
(A10)
N
6-Acetyl-30,50-O-(1,1,3,3-tetraisopropyldisiloxane-
1,3-diyl)-20-O-(trimethylsilyl)adenosine (A2). To a sus-
pension of adenosine A1 (1.0g; 3.742mmol) in DMF
(12ml) and pyridine (12ml), 1,3-dichloro-1,1,3,3-tetraiso-
propyldisiloxane (1.3g; 4.116mmol) was added dropwise.
The mixture was stirred for 2h at room temperature,
during which time it turned into a clear solution. Then,
chlorotrimethylsilane (947ml; 7.484mmol) was added and
stirring was continued for 2h. The resulting white
suspension was treated with acetyl chloride (292ml;
4.116mmol) and stirred for 1.5h with occasional shaking.
After completion of the reaction, the yellow solution was
quenched by addition of 5% aqueous NaHCO3 and
extracted with dichloromethane. The combined organic
phases were washed with brine, dried over Na2SO4 and
evaporated. The crude product was puriﬁed by column
chromatography on SiO2 (CH2Cl2/CH3OH, 99.8/0.2 –
99/1 v/v). Yield: 2.127g of A2 as white foam (91%). TLC
(CH2Cl2/CH3OH, 94/6): Rf=0.49;
1H-NMR (500MHz,
DMSO): d 0.15 (s, 9H, ((CH3)3)Si); 1.03 (m, 28H, 2 
((CH3)2CH)2Si); 2.26 (s, 3H, COCH3); 3.95 (dd, J=1.5,
8.0Hz, 1H, H1-C(50)); 4.07 (m, 1H, H-C(40)); 4.13
(dd, J=1.5, 8.0Hz, 1H, H2-C(50)); 4.72 (dd, J=2.7,
5.4Hz, 1H, H-C(30)); 4.77 (d, J=2.7Hz, 1H, H-C(20));
5.97 (s, 1H, H-C(10)); 8.47 (s, 1H, H-C(8)); 8.59 (s, 1H,
H-C(2)); 10.72 (s, br, 1H, H-N
6) p.p.m.;
13C-NMR
(75MHz, DMSO): d 0.65 ((CH3)3Si); 12.76, 12.83,
13.17, 17.23, 17.34, 17.40, 17.52, 17.61, 17.76 (2 
((CH3)2CH)2Si); 24.79 (COCH3); 60.70 (C(50)); 69.80
(C(30)); 75.57 (C(20)); 81.19 (C(40)); 90.23 (C(10)); 124.21;
142.38 (C(8)); 150.07, 151.36; 152.00 (C(2)); 169.25
(COCH3) p.p.m.; UV/Vis (MeOH):  max (")=270
(16000)nm (mol
 1dm
3cm
 1); ESI-MS (m/z): [M+H]
+
calcd for C27H49N5O6Si3, 624.96; found 624.19.
N
6-Acetyl-30,50-O-(1,1,3,3-tetraisopropyldisiloxane-
1,3-diyl)adenosine (A3). A mixture of p-toluenesulfonic
acid monohydrate (671mg; 3.526mmol), dioxane (20ml)
and molecular sieves (1.5g) was stirred for 2.5h at room
temperature. A solution of A2 (2.0g; 3.205mmol) in
dioxane (10ml) was added and stirring was continued for
1.5h. The reaction mixture was then quenched by the
addition of triethylamine (4.5ml), evaporated and coevap-
orated with dichloromethane. The crude product was
O
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Figure 1. Se-modiﬁed RNA for X-ray crystallography. (a)
20-Methylseleno-modiﬁed RNA represents a highly requested derivative
for RNA crystallography. (b) A single crystal with an anomalous
scattering center such as selenium is required during X-ray structure
determination using advanced techniques for phase determination, such
as MAD, SAD (single-wavelength anomalous diﬀraction) or SIRAS
(single isomorphous replacement with anomalous scattering). (c) Solid-
phase synthesis of 20-methylseleno RNA has been developed based on
50-O-(4,40-dimethoxytrityl) (DMT)-20-O-silyl protected nucleoside build-
ing blocks. (d) Goal of the present study is the synthesis of
20-methylseleno RNA by 20-O-bis(acetoxyethoxy)methyl (ACE) RNA
solid-phase synthesis. For this, novel building blocks and adaptation of
the established ACE solid-phase synthesis cycle are required.
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CH3OH, 99.5/0.5 – 97/3 v/v). Yield: 1.384g of A3 as white
foam (78%). TLC (CH2Cl2/CH3OH, 94/6): Rf=0.46;
1H-NMR (300MHz, CDCl3): d 1.09 (m, 28H, 2 
((CH3)2CH)2Si); 2.62 (s, 3H, COCH3); 3.41 (s, br, 1H,
HO-C(20)); 4.02–4.14 (m, 3H, H2-C(50), H-C(40));
4.60 (m, 1H, H-C(20)); 5.09 (m, 1H, H-C(30)); 6.02
(d, J=0.9Hz, 1H, H-C(10)); 8.18 (s, 1H, H-C(8));
8.62 (s, 1H, H-C(2)); 9.09 (s, br, 1H, H-N
6)p.p.m.;
13C-NMR (75MHz, CDCl3): d 12.63, 12.75, 13.02,
13.26, 16.88, 16.94, 16.96, 17.08, 17.23, 17.30, 17.39 (2 
((CH3)2CH)2Si); 25.64 (COCH3); 61.69 (C(50)); 70.79
(C(30)); 75.06 (C(20)); 82.26 (C(40)); 89.79 (C(10)); 122.43;
141.96 (C(8)); 149.38, 150.47; 152.31 (C(2)); 170.58
(COCH3) p.p.m.; UV/Vis (MeOH):  max (e)=271
(11700)nm (mol
 1dm
3cm
 1); ESI-MS (m/z): [M+H]
+
calcd for C24H41N5O6Si2, 552.78; found 552.16.
N
6-Acetyl-30,50-O-(1,1,3,3-tetraisopropyldisiloxane-
1,3-diyl)-20-O-(trifluoromethanesulfonyl)adenosine
(A4). To a solution of compound A3 (380mg;
0.689mmol) in CH2Cl2 (13ml), 4-dimethylaminopyridine
(253mg; 2.067mmol) was added at 08C. The mixture was
treated with triﬂuoromethanesulfonyl chloride (109ml;
1.034mmol) and stirred for 15min at 08C. The reaction
mixture was then diluted with CH2Cl2, washed with 5%
aqueous NaHCO3, dried over Na2SO4 and evaporated.
The crude product can be used for the next step without
further puriﬁcation. For analysis, the product was puriﬁed
by column chromatography on SiO2 (CH2Cl2/CH3OH,
100/0 – 99.3/0.7 v/v). Yield: 259mg of A4 as white foam
(55%). TLC (CH2Cl2/CH3OH, 94/6): Rf=0.51;
1H-NMR
(300MHz, CDCl3): d 1.08 (m, 28H, 2  ((CH3)2CH)2Si);
2.63 (s, 3H, COCH3); 4.05 (dd, J=2.6, 13.4Hz, 1H,
H1-C(50)); 4.12 (m, 1H, H-C(40)); 4.20 (m, 1H, H2-C(50));
5.23 (dd, J=4.8, 9.0Hz, 1H, H-C(30)); 5.77
(d, J=4.5Hz, 1H, H-C(20)); 6.17 (s, 1H, H-C(10)); 8.20
(s, 1H, H-C(8)); 8.61 (s, 1H, H-C(2)); 8.89 (s, br, 1H,
H-N
6)p.p.m.;
13C-NMR (75MHz, CDCl3): d 12.75, 12.80,
12.88, 13.22, 16.66, 16.73, 17.17, 17.21, 17.32 (2 
((CH3)2CH)2Si); 25.70 (COCH3), 59.53 (C(50)); 68.16
(C(30)); 77.19 (CF3); 81.63 (C(40)); 87.05 (C(10)); 87.99
(C(20)); 122.29; 141.48 (C(8)); 149.54, 150.20; 152.67
(C(2)); 170.55 (COCH3) p.p.m.; UV/Vis (MeOH):  max
(e)=270 (16100)nm (mol
 1dm
3cm
 1); ESI-MS (m/z):
[M+H]
+ calcd for C25H40F3N5O8SSi2, 684.85; found
684.20.
N
6-Acetyl-30,50-O-(1,1,3,3-tetraisopropyldisiloxane-
1,3-diyl)( -D-arabinofuranosyl)adenine (A5). To a solu-
tion of crude A4 (prepared from 744mg of A3;
1.348mmol) in toluene (36ml), potassium triﬂuoroacetate
(1.025g; 6.740mmol), 18-crown-6 (713mg; 2.696mmol)
and N-ethyldiisopropylamine (346ml; 2.022mmol) were
added. The mixture was stirred for 16h at 808C. After
completion of the reaction, the mixture was ﬁltrated over
celite and the solvent was evaporated. The residue was
then suspended in dichloromethane, and again ﬁltrated
over celite. The ﬁltrate was washed with 5% aqueous
NaHCO3, dried over Na2SO4 and evaporated. The crude
product was puriﬁed by column chromatography on SiO2
(CH2Cl2/CH3OH, 100/0 – 97.5/2.5 v/v). Yield: 498mg of
A5 as slightly yellow foam (67% over two steps). TLC
(CH2Cl2/CH3OH, 92/8): Rf=0.48;
1H-NMR (300MHz,
CDCl3): d 1.05 (m, 28H, 2  ((CH3)2CH)2Si); 2.50 (s, 3H,
COCH3); 3.88 (m, 1H, H-C(40)); 4.07 (m, 2H, H2-C(50));
4.26 (s, br, 1H, HO-C(20)); 4.61 (t, J=7.8Hz, 1H,
H-C(30)); 4.67 (m, 1H, H-C(20)); 6.28 (d, J=6.0Hz, 1H,
H-C(10)); 8.30 (s, 1H, H-C(8)); 8.53 (s, 1H, H-C(2)); 9.07
(s, br, 1H, H-N
6)p.p.m.;
13C-NMR (75MHz, CDCl3): d
12.49, 12.94, 13.07, 13.48, 16.90, 16.94, 17.02, 17.30, 17.35,
17.46 (2  ((CH3)2CH)2Si); 25.52 (COCH3), 61.62 (C(50));
75.06 (C(30)); 77.21 (C(20)); 81.54 (C(40)); 83.81 (C(10));
121.56; 142.82 (C(8)); 148.94, 150.98; 151.97 (C(2)); 170.69
(COCH3)p.p.m.; UV/Vis (MeOH):  max (e)=271
(16400) nm (mol
 1dm
3cm
 1); ESI-MS (m/z): [M+H]
+
calcd for C24H41N5O6Si2, 552.78; found 552.14.
N
6-Acetyl-30,50-O-(1,1,3,3-tetraisopropyldisiloxane-
1,3-diyl)-20-O-(trifluoromethanesulfonyl)( -D-arabinofur-
anosyl)adenine (A6). To a solution of compound A5
(49mg; 0.089mmol) in CH2Cl2 (1.7ml), 4-dimethylami-
nopyridine (32mg; 0.266mmol) was added at 08C. The
mixture was treated with triﬂuoromethanesulfonyl chlo-
ride (14ml; 0.133mmol) and stirred for 15min at 08C. The
reaction mixture was then diluted with CH2Cl2, washed
with 5% aqueous NaHCO3, dried over Na2SO4 and
evaporated. The crude product can be used for the next
step without further puriﬁcation. For analysis, the product
was puriﬁed by column chromatography on SiO2
(CH2Cl2/CH3OH, 100/0 – 99.3/0.7 v/v). Yield: 31mg of
A6 as white foam (51%). TLC (CH2Cl2/CH3OH, 94/6):
Rf=0.54;
1H-NMR (300MHz, CDCl3): d 1.05 (m, 28H,
2  ((CH3)2CH)2Si); 2.64 (s, 3H, COCH3); 3.98 (m, 1H,
H-C(40)); 4.15 (m, 2H, H2-C(50)); 5.39 (t, J=7.2Hz, 1H,
H-C(30)); 5.49 (t, J=6.3Hz, 1H, H-C(20)); 6.43
(d, J=6.0Hz, 1H, H-C(10)); 8.13 (s, 1H, H-C(8)); 8.66
(s, 1H, H-C(2)); 8.86 (s, br, 1H, H-N
6)p.p.m.;
13C-NMR
(75MHz, CDCl3): d 12.61-17.38 (2  ((CH3)2CH)2Si);
25.71 (COCH3); 61.99 (C(50)); 74.06 (C(30)); 77.19 (CF3);
81.00 (C(10)); 81.23 (C(40)); 88.27 (C(20)); 121.84; 141.84
(C(8)); 149.50, 150.78; 152.55 (C(2)); 170.47
(COCH3)p.p.m.; UV/Vis (MeOH):  max (e)=270
(20400)nm (mol
 1dm
3cm
 1); ESI-MS (m/z): [M+H]
+
calcd for C25H40F3N5O8SSi2, 684.85; found 684.11.
N
6-Acetyl-30,50-O-(1,1,3,3-tetraisopropyldisiloxane-
1,3-diyl)-20-methylseleno-20-deoxyadenosine (A7). Sodium
borohydride (204mg; 5.418mmol) was placed in a sealed
25ml two-necked round-bottom ﬂask, dried on high
vacuum for 15min to deplete oxygen, kept under argon
and suspended in dry THF (7.3ml). Dimethyldiselenide
(174ml; 1.806mmol) was slowly injected to this suspen-
sion, followed by dropwise addition of anhydrous ethanol;
0.2ml was required until gas bubbles started to occur in
the yellow mixture. The solution was stirred at room
temperature for 1.5h and the almost colorless solution
was injected into a solution of crude A6 (prepared
from 498mg of A5; 0.903mmol) in dry THF (8.6ml).
The reaction mixture was stirred at room temperature
for 30min. Then, aqueous 0.2M triethylammonium
acetate buﬀer (15ml, pH 7) was added, and the
972 Nucleic Acids Research, 2008, Vol. 36, No. 3solution was reduced to half the volume by evaporation.
Dichloromethane was added, and the organic layer was
washed twice with 0.2M triethylammonium acetate buﬀer
and ﬁnally with saturated sodium chloride solution. The
organic phase was dried over Na2SO4 and the solvent was
evaporated. The crude product was puriﬁed by column
chromatographyonSiO2(CH2Cl2/CH3OH,99.8/0.2–98/2
v/v). Yield: 335mg of A7 as white foam (59% over two
steps). TLC (CH2Cl2/CH3OH, 94/6): Rf=0.47;
1H-NMR
(300MHz, CDCl3): d 1.01 (m, 28H, 2  ((CH3)2CH)2Si);
1.99 (s, 3H, SeCH3); 2.62 (s, 3H, COCH3); 4.09 (m, 3H,
H2-C(50)+H-C(20)); 4.19 (m, 1H, H-C(40)); 4.89
(t, J=6.8Hz, 1H, H-C(30)); 6.31 (d, J=3.9Hz, 1H,
H-C(10)); 8.26 (s, 1H, H-C(8)); 8.66 (s, 1H, H-C(2)); 8.89
(s, br, 1H, H-N
6)p.p.m.;
13C-NMR (75MHz, CDCl3):
d 3.40 (SeCH3); 12.70, 12.95, 13.14, 13.47, 16.88, 16.98,
17.13, 17.28, 17.29, 17.34, 17.46 (2  ((CH3)2CH)2Si); 25.65
(COCH3); 47.12 (C(20)); 61.73 (C(50)); 71.47 (C(30)); 84.68
(C(40)); 90.14 (C(10)); 122.36; 141.28 (C(8)); 149.25, 150.57;
152.37 (C(2)); 170.43 (COCH3) p.p.m.; UV/Vis (MeOH):
 max (e)=271 (17300) nm (mol
 1dm
3cm
 1); ESI-MS
(m/z): [M+H]
+ calcd for C25H43N5O5SeSi2, 629.77; found
629.98.
N
6-Acetyl-20-methylseleno-20-deoxyadenosine
(A8). Compound A7 (192mg; 0.305mmol) was dissolved
in a mixture of 1M tetrabutylammonium ﬂuoride/0.5M
acetic acid in THF (1.3ml). The solution was stirred for
2h at room temperature and the reaction progress was
monitored via TLC. Then, the solvent was evaporated and
the residue dried under high vacuum. The crude product
was puriﬁed by column chromatography on SiO2
(CH2Cl2/CH3OH, 100/0 – 97/3 v/v). Yield: 111mg of A8
as white foam (94%). TLC (CH2Cl2/CH3OH, 90/10):
Rf=0.42;
1H-NMR (300MHz, DMSO): d 1.57 (s, 3H,
SeCH3); 2.25 (s, 3H, COCH3); 3.58 (m, 1H, H1-C(50));
3.65 (m, 1H, H2-C(50)); 4.00 (m, 1H, H-C(40)); 4.18 (dd,
J=3.0, 9.0Hz, 1H, H-C(20)); 4.36 (m, 1H, H-C(30)); 5.10
(t, J=6.0Hz, 1H, HO-C(50)); 5.86 (d, J=6.0Hz, 1H,
HO-C(30)); 6.36 (d, J=9.0Hz, H-C(10)); 8.66 (s, 1H,
H-C(2)); 8.74 (s, 1H, H-C(8)); 10.68 (s, br, 1H, H-N
6)
p.p.m.;
13C-NMR (75MHz, DMSO): d 2.87 (SeCH3);
24.81 (COCH3); 46.73 (C(20)); 62.14 (C(50)); 73.21 (C(30));
87.98 (C(40)); 89.90 (C(10)); 124.00; 143.21 (C(8)); 150.17,
152.17; 152.29 (C(2)); 169.30 (COCH3) p.p.m.; UV/Vis
(MeOH):  max (e)=271 (15000)nm (mol
 1dm
3cm
 1);
ESI-MS (m/z): [M+H]
+ calcd for C13H17N5O4Se, 387.27;
found 387.84.
N
6-Acetyl-50-O-[benzhydryloxy-bis(trimethylsilyloxy)
silyl]-20-methylseleno-20-deoxyadenosine (A9). Solution
A: To a solution of compound A8 (60mg; 0.155mmol)
in DMF (0.5ml), N,N-diisopropylamine (22ml;
0.155mmol) was added and the mixture was cooled
to 08C. Solution B: N,N-diisopropylamine (53ml;
0.372mmol) was added dropwise to a solution of
benzhydryloxy-bis(trimethylsilyloxy)chlorosilane (132mg;
0.310mmol) in dichloromethane (0.3ml) at 08C. Solution
B was added to solution A at 08C in three portions
(aliquots of 0.5/0.25/0.25 every 30min) and the reaction
progress was monitored by TLC. After 2h, the reaction
mixture was quenched by addition of 5% sodium
bicarbonate solution and extracted with dichloromethane.
The combined organic phases were washed with brine,
dried over Na2SO4 and evaporated. The crude product
was puriﬁed by column chromatography on SiO2 (hexane/
ethyl acetate, 1/1 v/v). Yield: 87mg of A9 as colorless oil
(72%). TLC (ethyl acetate/hexane, 4/1): Rf=0.46;
1H-NMR (300MHz, CDCl3): d 0.08, 0.10 (2s, 18H, 2 
(CH3)3Si); 1.84 (s, 3H, SeCH3); 2.66 (s, 3H, COCH3); 2.73
(m, 1H, HO-C(30)); 3.82 (m, 2H, H2-C(50)); 3.95 (dd,
J=5.1, 8.4Hz, 1H, H-C(20)); 4.18 (m, 1H, H-C(40)); 4.28
(m, 1H, H-C(30)); 5.94 (s, 1H, OCH(Ph)2); 6.26 (d,
J=9.0Hz, 1H, H-C(10)); 7.26–7.36 (m, 10H, H-C(ar));
8.28 (s, 1H, H-C(8)); 8.66 (s, br, 2H, H-C(2)+H-N
6)
p.p.m.;
13C-NMR (75MHz, CDCl3): d 1.50 (2 
(CH3)3Si); 4.23 (SeCH3); 25.68 (COCH3); 49.68 (C(20));
63.14 (C(50)); 72.75 (C(30)); 77.05 (OCH(Ph)2); 85.67
(C(40)); 88.19 (C(10)); 121.88; 126.31, 126.32, 127.33,
128.30 (C(ar)); 141.49 (C(8)); 143.83, 143.85, 149.13,
151.36; 152.36 (C(2)); 170.62 (COCH3) p.p.m.; UV/Vis
(MeOH):  max (e)=271 (17500)nm (mol
 1dm
3cm
 1);
HR-ESI-MS (m/z): [M+Na]
+ calcd for
C32H45N5O7SeSi3, 798.1689; found 798.1677.
N
6-Acetyl-50-O-[benzhydryloxy-bis(trimethylsilyloxy)
silyl]-20-methylseleno-20-deoxyadenosine 30-(methyl-N,
N-diisopropyl)phosphoramidite (A10). Compound A9
(139mg; 0.179mmol) was dissolved in a mixture of
N-ethyldimethylamine (194ml; 1.794mmol) in dry dichlo-
romethane (2.3ml) under argon. After 15min at room
temperature, methyl-N,N-diisopropylchlorophosphorami-
dite (53mg; 0.269mmol) was slowly added and the
solution was stirred at room temperature for 2h. The
reaction mixture was diluted with dichloromethane,
washed with half-saturated sodium bicarbonate solution,
dried over Na2SO4 and evaporated. The crude product
was puriﬁed by column chromatography on SiO2 (ethyl
acetate/hexane, 2/3 – 1/1 v/v (+0.5% Et3N)). Yield:
117mg of A10 (mixture of diastereomers) as colorless oil
(70%). TLC (ethyl acetate/hexane, 7/3): Rf=0.47, 0.53;
1H-NMR (500MHz, CDCl3): d 0.07-0.09 (4s, 36H, 4 
(CH3)3Si); 1.19-1.27 (m, 24H, 2  ((CH3)2CH)2N); 1.52,
1.57 (2s, 6H, 2  SeCH3); 2.66 (s, 6H, 2  COCH3); 3.35
(d, J=13.5Hz, 3H, POCH3); 3.48 (d, J=13.5Hz, 3H,
POCH3); 3.63 (m, 4H, 2  ((CH3)2CH)2N); 3.80–3.96
(m, 6H, 2  H-C(20)+2  H2-C(50)); 4.31 (m, 2H, 2 
H-C(40)); 4.57 (dd, J=5.4, 9.3Hz, 1H, H-C(30)); 4.66
(dd, J=6.2, 11.0Hz, 1H, H-C(30)); 5.95, 5.96 (2s, 2H, 2 
OCH(Ph)2); 6.45 (2d, J=8.0, 8.5Hz, 2H, 2  H-C(10));
7.19–7.37 (m, 20H, H-C(ar)); 8.27, 8.28 (2s, 2H, 2 
H-C(8)); 8.53 (s, br, 2H, 2  H-N
6); 8.66, 8.68 (2s, 2H,
H-C(2))p.p.m.;
31P-NMR (121MHz, CDCl3): d 150.3,
153.0p.p.m.; UV/Vis (MeOH):  max (e)=271 (17400)nm
(mol
 1dm
3cm
 1); HR-ESI-MS (m/z): [M+Na]
+ calcd
for C39H61N6O8PSeSi3, 959.2660; found 959.2701.
Synthesisof2’-methylselenoguanosinephosphoramidite(G3)
N
2-Acetyl-50-O-[benzhydryloxy-bis(trimethylsilyloxy)
silyl]-20-methylseleno-20-deoxyguanosine (G2). Solution
A: To a solution of compound G1 [reference (6)]
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amine (179ml; 1.99mmol) was added and the mixture
was cooled to 08C. Solution B: N,N-diisopropylamine
(179ml; 1.99mmol) was added dropwise to a solution of
benzhydryloxy-bis(trimethylsilyloxy)chlorosilane (846mg;
1.99mmol) in dichloromethane (5.0ml) at 08C. Solution B
was added to solution A at 08C in three portions (aliquots
of 0.5/0.25/0.25 every 30min) and the reaction progress
was monitored by TLC. After 2h, the reaction mixture
was quenched by addition of 5% sodium bicarbonate
solution and extracted with dichloromethane. The com-
bined organic phases were washed with brine, dried over
Na2SO4 and evaporated. The crude product was puriﬁed
by column chromatography on SiO2 (CH2Cl2/acetone,
95/5 – 85/15 v/v). Yield: 358mg of G2 as colorless oil
(46%). TLC (CH2Cl2/acetone, 7/3): Rf=0.71;
1H-NMR
(300MHz, CDCl3): d 0.05–0.06 (2s, 18H, 2  (CH3)3Si);
1.65 (s, 3H, SeCH3); 2.31 (s, 3H, COCH3); 3.57 (m, 1H,
H-C(20)); 3.67 (m, 1H, HO-C(30)); 3.77 (m, 2H, H2-C(50));
4.15 (m, 1H, H-C(40)); 4.31 (m, 1H, H-C(30)); 5.92 (d,
J=9Hz, 1H, H-C(10)); 5.93 (s, 1H, OCH(Ph)2); 7.16-7.34
(m, 10H, H-C(ar)); 8.01 (s, 1H, H-C(8)); 10.49 (s, br, 1H,
H-N
2); 12.24 (s, br, 1H, H-N(1)) p.p.m.;
13C-NMR
(75MHz, CDCl3): d 1.52 (2  (CH3)3Si); 3.63 (SeCH3);
24.28 (COCH3); 49.80 (C(20)); 63.52 (C(50)); 73.38 (C(30));
77.05 (OCH(Ph)2); 85.98 (C(40)); 87.96 (C(10)); 120.83,
126.25, 126.32, 127.33, 128.29 (C(ar)); 137.31 (C(8));
143.72, 143.77, 147.79, 149.13 (C(ar)); 156.16 (C(6));
172.95 (COCH3)p.p.m.; UV/Vis (MeOH):  max (e)=256
(19300) nm (mol
 1dm
3cm
 1); HR-ESI-MS (m/z):
[M+Na]
+ calcd for C32H45N5O8SeSi3, 815.1656; found
815.1651.
N
2-Acetyl-50-O-[benzhydryloxy-bis(trimethylsilyloxy)
silyl]-20-methylseleno-20-deoxyguanosine 30-(methyl-N,
N-diisopropyl)phosphoramidite (G3). Compound G2
(179mg; 0.226mmol) was dissolved in a mixture of
N-ethyldimethylamine (74ml; 0.680mmol) in dry dichlo-
romethane (5.0ml) under argon. After 15min at room
temperature, methyl-N,N-diisopropylchlorophosphorami-
dite (67mg; 0.340mmol) was slowly added and the
solution was stirred at room temperature for 2h. The
reaction mixture was diluted with dichloromethane,
washed with half-saturated sodium bicarbonate solution,
dried over Na2SO4 and evaporated. The crude product
was puriﬁed by column chromatography on SiO2
(CH2Cl2/acetone, 100/0 – 95/5 v/v). Yield: 172mg of G3
(mixture of diastereomers) as colorless oil (80%). TLC
(CH2Cl2/acetone, 8/2): Rf=0.48, 0.63;
1H-NMR
(500MHz, CDCl3): d 0.07 (m, 36H, 4  (CH3)3Si); 1.18-
1.27 (m, 24H, 2  ((CH3)2CH)2N); 1.46, 1.50 (2s, 6H, 2 
SeCH3); 2.14, 2.15 (2s, 6H, 2  COCH3); 3.35
(d, J=13.3Hz, 3H, POCH3); 3.47 (d, J=13.2Hz, 3H,
POCH3); 3.63 (m, 4H, 2  ((CH3)2CH)2N); 3.76 (m, 4H,
2  H2-C(50)); 3.87 (m, 2H, 2  H-C(20)); 4.25, 4.29 (2m,
2H, 2  H-C(40)); 4.45, 4.65 (2m, 2H, H-C(30)); 5.97, 5.98
(2s, 2H, 2  OCH(Ph)2); 6.10, 6.15 (2d, J=9.6, 9.6Hz,
2H, 2  H-C(10)); 7.19-7.34 (m, 20H, H-C(ar)); 7.92 (s, 2H,
2  H-C(8)); 8.46 (s, br, 2H, 2  H-N
2); 11.85 (s, br, 2H,
2  H-N(1)) p.p.m.;
31P-NMR (121MHz, CDCl3): d 150.5,
152.8p.p.m.; UV/Vis (MeOH):  max (e)=257 (20800)nm
(mol
 1dm
3cm
 1); HR-ESI-MS (m/z): [M+H]
+ calcd for
C39H61N6O9PSeSi3, 953.2790; found 953.2807.
Synthesis of2’-methylseleno cytidine phosphoramidite (C4)
N
4-Acetyl-20-methylseleno-20-deoxycytidine (C2). N
4-
Acetyl-30-O-tert-butyldimethylsilyl-50-O-(4,40-dimethoxy-
trityl)-20-methylseleno-20-deoxycytidine C1 [reference (4)]
(824mg; 1.055mmol) was dissolved in a mixture of 1.0M
tetrabutylammonium ﬂuoride/0.5M acetic acid in THF
(3.0ml). The solution was stirred for 18h at room
temperature, and the reaction progress was monitored
via TLC. Then, the solvent was evaporated and the
residue partitioned between CH2Cl2 and water. The
organic layer was concentrated in vacuum and then
detritylation was initiated by addition of 4.0ml of
formic acid. The reaction was complete after 2min.
CH3OH was added followed by evaporation and coeva-
poration with CH3OH and toluene for several times. For
workup, the crude product was partitioned between water
and CH2Cl2. The aqueous layer was evaporated and dried
under high vacuum. Yield: 305mg of C2 as white powder
(80%). TLC (CH2Cl2/CH3OH, 90/10): Rf=0.38;
1H-NMR (300MHz, DMSO): d 1.89 (s, 3H, SeCH3);
2.10 (s, 3H, COCH3); 3.56 (m, 1H, H-C(20)); 3.58 (m, 1H,
H1-C(50)); 3.64 (m, 1H, H2-C(50)); 4.18 (m, 1H, H-C(40));
4.22 (m, 1H, H-C(30)); 5.17 (s, 1H, HO-C(50)); 5.78 (s, 1H,
HO-C(30)); 6.25 (d, J=7.8Hz, 1H, H-C(10)); 7.20
(d, J=7.8Hz, 1H, H-C(5)); 8.34 (d, J=7.8Hz, 1H,
H-C(6)); 10.92 (s, br, 1H, H-N
4)p.p.m.;
13C-NMR
(75MHz, DMSO): d 2.33 (SeCH3); 24.25 (COCH3);
47.55 (C(20)); 60.70 (C(50)); 71.22 (C(30)); 86.41 (C(40));
89.97 (C(10)); 95.66 (C(5)); 145.30 (C(6)); 154.61, 162.28;
170.96 (COCH3) p.p.m.; UV/Vis (MeOH):  max (e)=262
(12900)nm (mol
 1dm
3cm
 1); ESI-MS (m/z): [M+H]
+
calcd for C12H17N3O5Se, 363.14; found 363.03.
N
4-Acetyl-50-O-[benzhydryloxy-bis(trimethylsilyloxy)
silyl]-20-methylseleno-20-deoxycytidine (C3). Solution A:
To a solution of compound C2 (80mg; 0.221mmol) in
DMF (1.0ml), N,N-diisopropylamine (31ml; 0.221mmol)
was added and the mixture was cooled to 08C. Solution B:
N,N-diisopropylamine (70ml; 0.497mmol) was added
dropwise to a solution of benzhydryloxy-bis(trimethylsi-
lyloxy)chlorosilane (188mg; 0.442mmol) in dichloro-
methane (1.0ml) at 08C. Solution B was added to
solution A at 08C in three portions (aliquots of 0.5/0.25/
0.25 every 30min) and the reaction progress was
monitored by TLC. After 2h, the reaction mixture was
quenched by addition of 5% sodium bicarbonate solution
and extracted with dichloromethane. The combined
organic phases were washed with brine, dried over
Na2SO4 and evaporated. The crude product was puriﬁed
by column chromatography on SiO2 (CH2Cl2/acetone,
1/0 – 1/1 v/v). Yield: 90mg of C3 as colorless oil (54%).
TLC (CH2Cl2/acetone, 3/7): Rf=0.65;
1H-NMR
(300MHz, CDCl3): d 0.12–0.24 (2s, 18H, 2  (CH3)3Si);
2.14 (s, 3H, SeCH3); 2.22 (s, 3H, COCH3); 2.61 (m, 1H,
HO-C(30)); 3.38 (m, 1H, H-C(20)); 3.78 (m, 1H, H1-C(50));
3.91 (m, 1H, H2-C(50)); 4.07 (m, 1H, H-C(40)); 4.10
(m, 1H, H-C(30)); 5.96 (s, 1H, OCH(Ph)2); 6.35
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7.35 (d, J=7.5Hz, 1H, H-C(5)); 8.26 (d, J=7.5Hz, 1H,
H-C(6)); 8.37 (s, br, 1H, H-N
4)p.p.m.;
13C-NMR
(75MHz, CDCl3): d 1.54 (2  (CH3)3Si); 4.36 (SeCH3);
24.87 (COCH3); 51.29 (C(20)); 62.55 (C(50)); 70.90 (C(30));
77.09 (OCH(Ph)2); 85.20 (C(40)); 89.01 (C(10)); 97.29
(C(5)); 126.21, 127.37, 128.33, 143.72 (C(ar)); 144.38
(C(6)); 155.36, 162.96 (C(ar)); 170.97 (COCH3)
p.p.m.; UV/Vis (MeOH):  max (e)=263 (12500)nm
(mol
 1dm
3cm
 1); HR-ESI-MS (m/z): [M+Na]
+ calcd
for C31H45N3O8SeSi3, 775.1595; found 775.1606.
N
4-Acetyl-50-O-[benzhydryloxy-bis(trimethylsilyloxy)
silyl]-20-methylseleno-20-deoxycytidine 30-(methyl-N,N-di-
isopropyl)phosphoramidite (C4). Compound C3 (280mg;
0.373mmol) was dissolved in a mixture of N-ethyldi-
methylamine (404ml; 3.729mmol) in dry dichloromethane
(5.0ml) under argon. After 15min at room temperature,
methyl-N,N-diisopropylchlorophosphoramidite (111mg;
0.559mmol) was slowly added and the solution was
stirred at room temperature for 2h. The reaction mixture
was diluted with dichloromethane, washed with half-
saturated sodium bicarbonate solution, dried over Na2SO4
and evaporated. The crude product was puriﬁed by
column chromatography on SiO2 (CH2Cl2/acetone, 99/
1–93/7 v/v). Yield: 235mg of C4 (mixture of diastereo-
mers) as colorless oil (69%). TLC (CH2Cl2/acetone, 7/3):
Rf=0.37, 0.52;
1H-NMR (500MHz, CDCl3): d 0.06-0.09
(4s, 36H, 4  (CH3)3Si); 1.14–1.27 (m, 24H, 2 
((CH3)2CH)2N); 1.96, 2.07 (2s, 6H, 2  SeCH3); 2.24
(s, 6H, 2  COCH3); 3.26, 3.49 (2d, 2H, 2  H-C(20)); 3.31
(d, J=13.5Hz, 3H, POCH3); 3.44 (d, J=13.5Hz, 3H,
POCH3); 3.60 (m, 4H, 2  ((CH3)2CH)2N); 3.79–3.96
(m, 4H, 2  H2-C(50)); 4.23 (m, 2H, 2  H-C(40)); 4.46
(m, 2H, H-C(30)); 5.93 (s, 2H, 2  OCH(Ph)2); 6.43, 6.49
(2d, J=5.5, 7.5Hz, 2H, 2  H-C(10)); 7.18–7.35 (m, 22H,
H-C(ar), H-C(5)); 8.15, 8.25 (2d, J=7.8, 7.3Hz, 2H, 2 
H-C(6)); 8.96, 9.05 (2s, br, 2H, 2  H-N
4)p.p.m.;
31P-NMR (121MHz, CDCl3): d 150.6, 152.7p.p.m.;
UV/Vis (MeOH):  max (e)=264 (12800)nm (mol
 1dm
3
cm
 1); HR-ESI-MS (m/z): [M+Na]
+ calcd for
C38H61N4O9PSeSi3, 936.2567; found 936.2587.
Synthesis of2’-methylseleno uridine phosphoramidite (U4)
20-Methylseleno-20-deoxyuridine (U2). A solution of 50-O-
(4,40-dimethoxytrityl)-20-methylseleno-20-deoxyuridine U1
[reference (4)] (600mg; 0.962mmol) in dichloromethane/
formic acid (14.4ml; 5/1 v/v) was stirred at room
temperature for 1h. After addition of methanol (5ml),
the solvents were evaporated at reduced pressure. The
residue was coevaporated several times with methanol and
toluene until a clear syrup was obtained which was
dissolved in dichloromethane/water. Extraction of the
product into water, evaporation to dryness and coeva-
poration with methanol yielded 306mg of U2 as white
foam (99%). TLC (CH2Cl2/MeOH, 88/12): Rf=0.47;
1H-NMR (300MHz, DMSO): d 1.87 (s, 3H, SeCH3); 3.51
(dd, J=5.6, 8.6Hz, 1H, H-C(20)); 3.58 (m, 2H, H2-C(50));
3.88 (m, 1H, H-C(40)); 4.21 (m, 1H, H-C(30)); 5.09 (s, br,
1H, HO-C(50)); 5.71 (d, J=9.0Hz, 1H, H-C(5)); 5.75
(m, 1H, HO-C(30)); 6.20 (d, J=9.0Hz, 1H, H-C(10));
7.86 (d, J=9.0Hz, 1H, H-C(6)); 11.36 (s, br, 1H,
H-N(3))p.p.m.;
13C-NMR (75MHz, DMSO): d 2.93
(SeCH3); 46.80 (C(20)); 61.81 (C(50)); 72.81 (C(30)); 87.04
(C(40)); 89.07 (C(10)); 102.76 (C(5)); 140.91 (C(6)); 151.12
(C(2)); 163.36 (C(4)) p.p.m.; UV/Vis:  max (e)=260
(8700)nm (mol
 1dm
3cm
 1); ESI-MS (m/z): [M-H]
 
calcd for C10H14N2O5Se, 320.19; found 320.94.
50-O-[Benzhydryloxy-bis(trimethylsilyloxy)silyl]-
20-methylseleno-20-deoxyuridine (U3).
Preparation starting with U2. Solution A: To a solution of
compound U2 (299mg; 0.933mmol) in DMF (2ml),
N,N-diisopropylamine (132ml; 0.933mmol) was added
and the mixture was cooled to 08C. Solution B: N,N-
diisopropylamine (317ml; 2.237mmol) was added drop-
wise to a solution of benzhydryloxy-bis(trimethylsilyloxy)
chlorosilane (793mg; 1.866mmol) in dichloromethane
(1.8ml) at 08C. Solution B was added to solution A at
08C in three portions (aliquots of 0.5/0.25/0.25 every
30min) and the reaction progress was monitored by TLC.
After 2h, the reaction mixture was quenched by addition
of 5% sodium bicarbonate solution and extracted with
dichloromethane. The combined organic phases were
washed with brine, dried over Na2SO4 and evaporated.
The crude product was puriﬁed by column chromatogra-
phy on SiO2 (hexane/ethyl acetate, 4/1 – 1/1 v/v). Yield:
481mg of U3 as white foam (73%).
Preparation starting with U6. Sodium borohydride
(18mg; 0.476mmol) was placed in a sealed 25ml two-
necked round-bottom ﬂask, dried on high vacuum for
15min to deplete oxygen, kept under argon, and
suspended in dry THF (0.6ml). Dimethyldiselenide
(15ml; 0.159mmol) was slowly injected to this suspension,
followed by dropwise addition of anhydrous ethanol; 25ml
was required until gas bubbles started to occur in the
yellow mixture. The solution was stirred at room
temperature for 1h, and the almost colorless solution
was injected into a solution of U6 (48mg; 0.078mmol) in
dry THF (0.8ml). The reaction mixture was stirred at
room temperature for 2h. Then, aqueous 0.1M triethyl-
ammonium acetate buﬀer (5ml, pH 7) was added, and the
organic solvent was removed by evaporation. Water was
added, and the solution extracted with dichloromethane.
The organic phase was dried over Na2SO4, and the
solvent was evaporated. The crude product was
puriﬁed by column chromatography on SiO2 (CH2Cl2/
CH3OH, 99/1 – 99/2 v/v). Yield: 33mg of U3 as white
foam (59%).
TLC (ethyl acetate/hexane, 1/1): Rf=0.48;
1H-NMR
(300MHz, CDCl3): d 0.11, 0.12 (2s, 18H, 2  (CH3)3Si);
2.03 (s, 3H, SeCH3); 2.66 (m, 1H, HO-C(30)); 3.29 (dd,
J=4.8, 8.4Hz, 1H, H-C(20)); 3.86 (m, 2H, H2-C(50)); 4.15
(m, 2H, H-C(30), H-C(40)); 5.59 (d, J=8.1Hz, 1H,
H-C(5)); 5.95 (s, 1H, OCH(Ph)2); 6.19 (d, J=8.4Hz,
1H, H-C(10)); 7.31 (m, 10H, H-C(ar)); 7.77 (d, J=8.1Hz,
1H, H-C(6)); 8.27 (s, br, 1H, H-N(3)) p.p.m.;
13C-NMR
(75MHz, CDCl3): d 1.54 (2  (CH3)3Si); 4.22 (SeCH3);
50.08 (C(20)); 63.26 (C(50)); 71.97 (C(30/40)); 77.13
(OCH(Ph)2); 85.11 (C(30/40)); 87.15 (C(10)); 103.01 (C(5));
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143.64, 143.67 (C(ar)); 150.39 (C(2)); 162.80 (C(4))
p.p.m.; UV/Vis:  max (e)=260 (7800)nm
(mol
 1dm
3cm
 1); HR-ESI-MS (m/z): [M+Na]
+ calcd
for C29H42N2O8SeSi3, 733.1311; found 733.1321.
50-O-[Benzhydryloxy-bis(trimethylsilyloxy)silyl]-
20-methylseleno-20-deoxyuridine 30-(methyl-N,N-diisopro-
pyl)phosphoramidite (U4). Compound U3 (106mg;
0.150mmol) was dissolved in a mixture of N-ethyldi-
methylamine (162ml; 1.50mmol) in dry dichloromethane
(2ml) under argon. After 15min at room temperature,
methyl-N,N-diisopropylchlorophosphoramidite (45mg;
0.225mmol) was slowly added and the solution was
stirred at room temperature for 2h. The reaction was
quenched by the addition of methanol (0.1ml). The
reaction mixture was diluted with dichloromethane,
extracted with saturated sodium bicarbonate solution,
dried over Na2SO4 and the solvent was evaporated. The
crude product was puriﬁed by column chromatography on
SiO2 (ethyl acetate/hexane, 2/8–3/7 v/v (+0.5% NEt3)).
Yield: 107mg of U4 (mixture of diastereomers) as thick,
colorless oil (84%). TLC (ethyl acetate/hexane, 3/7):
Rf=0.50;
1H-NMR (500MHz, CDCl3): d 0.07, 0.08,
0.09, 1.10 (4s, 36H, 4  (CH3)3Si); 1.17–1.29 (m, 24H, 2 
((CH3)2CH)2N); 1.92, 1.96 (2s, 6H, 2  SeCH3); 3.17
(m, 1H, H-C(20)); 3.34 (m, 4H, H-C(20), POCH3); 3.49
(d, J=13.1Hz, 3H, POCH3); 3.66 (m, 4H, 2 
((CH3)2CH)2N); 3.83 (m, 4H, 2  H2-C(50)); 4.23 (m, 2H,
2  H-C(40)); 4.47, 4.55 (2m, 2H, 2  H-C(30)); 5.50 (m, 2H,
2  H-C(5)); 5.93 (s, 2H, 2  OCH(Ph)2); 6.38 (2d,
J=9Hz, 2H, 2  H-C(10)); 7.22-7.32 (m, 20H, H-C(ar));
7.70, 7.74 (2d, J=8.2Hz, 2H, 2  H-C(6)); 8.61 (s, br, 2H,
2  H-N(3)) p.p.m.;
31P-NMR (121MHz, CDCl3):
d 150.3, 153.0p.p.m.; UV/Vis:  max (e)=260 (8400) nm
(mol
 1dm
3cm
 1); HR-ESI-MS (m/z): [M+Na]
+ calcd for
C36H58N3O9PSeSi3, 894.2282; found 894.2310.
50-O-[Benzhydryloxy-bis(trimethylsilyloxy)silyl]-
2,20-anhydro uridine (U6). Solution A: A solution of
2,20-anhydro uridine U5 [reference (4)] (25mg;
0.111mmol) in pyridine (2.5ml) was cooled to  158C.
Solution B: Benzhydryloxy-bis(trimethylsilyloxy)chlorosi-
lane (118mg; 0.277mmol) was added to dichloromethane
(1.06ml) at  158C. Solution B was added to solution A at
 158C in 5 portions (aliquots of 0.5 over 3.5h) and the
reaction progress was monitored by TLC. After 4h, the
reaction mixture was quenched by addition of 5% citric
acid solution and extracted with dichloromethane. The
combined organic phases were washed with water and 5%
sodium bicarbonate solution, dried over Na2SO4 and
evaporated. The crude product was puriﬁed by column
chromatography on SiO2 (CH2Cl2/CH3OH, 99/1 – 93/7
v/v). Yield: 32mg of U6 as white foam (47%). TLC
(CH2Cl2/CH3OH, 92/8): Rf=0.47;
1H-NMR (300MHz,
CDCl3): d  0.02,  0.01 (2s, 18H, 2  (CH3)3Si); 3.42
(m, 2H, H2-C(50)); 4.04 (m, 1H, H-C(40)); 4.36 (m, 1H,
H-C(30)); 4.58 (s, br, 1H, HO-C(30)); 5.25 (m, 1H,
H-C(20)); 5.84 (s, 1H, OCH(Ph)2); 5.93 (d, J=
7.44Hz, 1H, H-C(5)); 6.04 (d, J=5.73Hz, 1H, H-C(10));
7.21 (m, 11H, H-C(6), H-C(ar))p.p.m.;
13C-NMR
(75MHz, CDCl3): d 1.57 (2  (CH3)3Si); 62.40 (C(50));
75.58 (C(30)); 77.01 (OCH(Ph)2); 87.45 (C(40)); 89.40
(C(20)); 89.75 (C(10)); 110.25 (C(5)); 126.59, 127.40,
128.40 (C(ar)); 135.33 (C(6)); 144.07, 144.09 (C(ar));
159.94 (C(2)); 172.46 (C(4))p.p.m.; UV/Vis:  260
(e)=260 (9800)nm (mol
 1dm
3cm
 1); ESI-MS (m/z):
[M+H]
+ calcd for C28H38N2O8Si3, 615.88; found 615.29.
ACE RNA solid-phase synthesis of2’-methylseleno
nucleoside containing RNAs
20-O-ACE standard nucleoside phosphoramidites and the
corresponding solid-phase supports were obtained from
Dharmacon. Oligoribonucleotides containing 20-methylse-
leno nucleosides were synthesized on a slightly modiﬁed
Pharmacia instrumentation (Gene Assembler Plus with a
bypassed UV detection unit) following modiﬁed DNA/
RNA standard methods containing an additional cycle
step of treatment with DTT; desilylation (0.55min): 1.1M
HF/2.9M Et3N/DMF; coupling (3.0min): phosphorami-
dites/acetonitrile (0.1M 130ml) were activated by ben-
zylthiotetrazole/acetonitrile (0.3M 360ml); capping
(3 0.4min): A: Ac2O/sym-collidine/acetonitrile (20/30/
50), B: 4-(dimethylamino)pyridine/acetonitrile (0.5M),
A/B=1/1; oxidation (1.0min): I2 (10mM) in acetoni-
trile/sym-collidine/H2O (10/1/5); DTT treatment
(2.0min): DTT (100mM) in ethanol/H2O (2/3). A ready-
to-use synthesis method ﬁle is provided in the
Supplementary Data available online. Solutions of stan-
dard amidites, tetrazole solutions and acetonitrile were
dried over activated molecular sieves overnight. Solutions
of 20-methylseleno nucleoside phosphoramidites were only
dried for 4–6h over activated molecular sieves before
consumption.
Deprotection and purification of 2’-ACE-protected RNAs
with 2’-methylseleno modifications
After strand assembly, methyl groups were removed from
the phosphate backbone of the RNA attached at the
solid support by treatment with disodium 2-carbamoyl-
2-cyanoethylene-1,1-dithiolate trihydrate in DMF
(0.39M, 2.0ml) and DTT in H2O (2M, 150ml; ﬁnal
DTT concentration 150mM) for 20min at room
temperature, followed by ﬁltration of the beads. Then,
the beads were removed from the column and additionally
treated with DTT in H2O (150mM, 200ml) for 1–3h at
room temperature in a 1.5ml vial. Cleavage from the solid
support and deprotection of acyl groups was performed
by MeNH2 in H2O (40%, 0.74ml) and DTT in H2O
(2M, 60ml; ﬁnal DTT concentration 150mM). The
mixture was heated to 608C and held at this temperature
for 10min. Then, the solution was evaporated to dryness,
and removal of 20-O-orthoesters was accomplished by
treatment with N,N,N0,N0-tetramethylethylenediamine
(TEMED) acetate buﬀer (100mM, 1mL, pH 3.8) for
30min at 608C. The mixture was evaporated to dryness,
the residue dissolved in H2O (0.7ml), and the solution
loaded on a size exclusion column (Amersham HiPrep
26/10 Desalting; 2.6 10cm; Sephadex G25). The crude
RNA was eluted with H2O and dried.
976 Nucleic Acids Research, 2008, Vol. 36, No. 3Analysis of crude RNA products after deprotection was
performed by anion-exchange chromatography on a
Dionex DNAPac100 column (4 250mm) at 808C. Flow
rate: 1ml/min; eluant A: 25mM Tris–HCl (pH 8.0), 6M
urea; eluant B: 25mM Tris–HCl (pH 8.0), 0.5M NaClO4,
6M urea; gradient: 0–60% B in A within 45min;
UV-detection at 265nm. Crude RNA products were
puriﬁed on a semi-preparative Dionex DNAPac100
column (9 250mm). Flow rate: 2ml/min; gradient:
5–10% B in A within 20min. Fractions containing
RNA were loaded on a C18 SepPak cartridge (Waters/
Millipore), washed with 0.1–0.2M (Et3NH)HCO3,H 2O,
and eluted with H2O/CH3CN (6/4). RNA fractions were
lyophilized.
Massspectrometry of2’-methylseleno group
containing RNAs
All experiments were performed on a Finnigan LCQ
Advantage MAX ion trap instrumentation connected to
an Amersham Ettan micro LC system. RNAs were
analyzed in the negative-ion mode with a potential of
 4kV applied to the spray needle. LC: Sample (250 pmol
RNA dissolved in 30ml of 20mM EDTA solution; average
injection volume: 25–30ml); column (XTerraMS, C18
2.5mm; 1.0 50mm) at 218C; ﬂow rate: 30ml/min; eluant
A: 8.6mM TEA, 100mM 1,1,1,3,3,3-hexaﬂuoroisopropa-
nol in H2O (pH 8.0); eluant B: methanol; gradient:
0–100% B in A within 30min; UV-detection at 254nm.
Prior to each injection, column equilibration was per-
formed by eluting buﬀer A for 30min at a ﬂow rate of
30ml/min.
RESULTS AND DISCUSSION
2’-O-ACERNA synthesis method
The ACE method for chemical synthesis of RNA was
designed under the aspect that mildly acidic aqueous
conditions are most desirable for the ﬁnal 20-O deprotec-
tion of the synthesized RNA (19). The loss of orthogon-
ality in combination with the classic 50-O-DMT group was
an obstacle to using a mildly acid-labile 20-O protecting
group and thus, the concept was achieved based on the
ﬂuoride labile 50-O-bis(trimethylsilyloxy)cyclododecyloxy-
silyl ether (DOD), together with the 20-O-bis(2-acetoxy-
ethoxy)methyl (ACE) orthoester. The 30-OH group was
derivatized as methyl-N,N-diisopropylphosphoramidite,
since the cyanoethyl group turned out to be unstable
with ﬂuoride reagents. After oligonucleotide assembly, the
phosphate methyl protecting groups were removed with
disodium 2-carbamoyl-2-cyanoethylene-1,1-dithiolate tri-
hydrate in DMF. Then, basic conditions (40% aqueous
MeNH2) caused oligonucleotide cleavage from the solid
support, along with the removal of the acyl protecting
groups at the exocyclic amino groups and, importantly, of
the acetyl groups at the 20-orthoesters. The resulting
20-O-bis(2-hydroxyethoxy)methyl orthoesters being 10
times more acid labile than prior to the removal of the
acetyl groups, therefore required very mild acidic condi-
tions (pH 3.8, 30min, 608C) for the ﬁnal deprotection step
(9,19,23–25). For preparation of Se-modiﬁed RNA
oligonucleotides based on the ACE method, we have
elaborated the syntheses of appropriate nucleoside phos-
phoramidites as described subsequently.
Synthesis of 2’-methylseleno adenosinephosphoramidite
Our route began with the simultaneous protection of the
30- and 50-hydroxyl groups of commercially available
adenosine A1 using 1,3-dichloro-1,1,3,3-tetraisopropyldi-
siloxane (TIPDSCl2), followed by protection of the
20-hydroxyl group as trimethylsilyl ether and reaction
with acetyl chloride to furnish the N
6-acetyl adenosine
derivative A2 (Scheme 1). Then, the trimethylsilyl group
was cleaved by p-toluenesulfonic acid (26). Triﬂation of
the ribose 20-OH of compound A3 gave intermediate A4
which was converted into arabino nucleoside A5 in
diastereoselective manner by treatment with potassium
triﬂuoroacetate and 18-crown-6-ether. After triﬂation of
the arabinose 20-OH, compound A6 was reacted with
sodium methyl selenide, producing key diastereomer A7 in
high yields. Deprotection of the TIPDS moiety proceeded
straightforward using tetrabutylammonium ﬂuoride
(TBAF) and acetic acid. Derivative A8 was transformed
regioselectively into the 50-O protected analog A9 by using
benzhydryloxy-bis(trimethylsilyloxy)chlorosilane
(BzHCl). Conversion into the corresponding phosphor-
amidite A10 was achieved in good yields by reaction with
methyl-N,N-diisopropylchlorophosphoramidite. In princi-
ple, intermediate A8 would be alternatively accessible via
N
6-acetyl-50-O-(4,40-dimethoxytrityl)-30-O-{[(triisopropyl-
silyl)oxy]methyl} (TOM) adenosine which accumulates as
regioisomeric by-product during the synthesis of standard
20-O-TOM adenosine phosphoramidite (8). With this
precursor, introduction of the selenium moiety proceeds
in four steps along the lines described in reference (5),
followed by cleavage of the DMT group to provide
intermediate A8. Such a route, however, would involve ten
steps in total starting from adenosine, and overall yields
would signiﬁcantly suﬀer from the nearly 1:1 ratio of
20- and 30-O-TOM regioisomers obtained in the third step
of synthesis (8). Therefore, we decided to follow the
strategy depicted in Scheme 1; our route provides
phosphoramidite A10 in a 13% overall yield in nine
steps with seven chromatographic puriﬁcations; in total,
0.5g of A10 was prepared in the course of this study.
Synthesis of 2’-methylseleno guanosinephosphoramidite
For the guanosine building block, we expanded a
previously developed route to obtain N
2-acetyl-50-O-
(4,40-dimethoxytrityl)-20-methylseleno-20-deoxyguanosine
phosphoramidite (6). Brieﬂy, commercially available
9-[ -D-arabinofuranosyl]guanine was reacted with 1,3-
dichloro-1,1,3,3-tetraisopropyldisiloxane (TIPDSCl2)t o
protect the 30- and 50-hydroxyl groups simultaneously.
Then, the 20-hydroxyl group together with the exocyclic
N
2-amino group were acetylated, followed by protection
of the guanine lactam moiety with a O
6-(4-nitrophenyl)-
ethyl (NPE) group introduced under Mitsunobu condi-
tions (6). Release of the 20-OH, transformation into the
desired 20-methylseleno moiety, and simultaneous depro-
tection of the NPE and TIPDS groups yielded derivative
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978 Nucleic Acids Research, 2008, Vol. 36, No. 3G1 (Scheme 2). This compound was then transformed
regioselectively into the 50-O protected analog G2 by using
benzhydryloxy-bis(trimethylsilyloxy)chlorosilane(BzHCl).
Conversion into the corresponding phosphoramidite G3
was achieved in good yields by reaction with methyl-N,N-
diisopropylchlorophosphoramidite. Our route provides
phosphoramidite G3 in a 4% overall yield in nine steps
with six chromatographic puriﬁcations; in total, 0.2g of
G3 was prepared in the course of this study.
Synthesis of2’-methylseleno cytidine phosphoramidite
For synthesis of the Se-modiﬁed cytidine building block,
we relied on a previously developed route to obtain N
4-
acetyl-50-O-(4,40-dimethoxytrityl)-20-methylseleno-20-de-
oxycytidine phosphoramidite (4). The strategy involved
transformationofthenucleobasefromthereadilyavailable
30-O-tert-butyldimethylsilyl-50-O-(4,40-dimethoxytrityl)-20-
methylseleno-20-deoxyuridine (4) into the corresponding
cytidine derivative C1 (Scheme 3). After deprotection,
compound C2 was reacted regioselectively with benzhy-
dryloxy-bis(trimethylsilyloxy)chlorosilane (BzHCl) to fur-
nish the 50-O protected analog C3. Conversion into the
corresponding phosphoramidite C4 was achieved in good
yields by reaction with methyl-N,N-diisopropylchloropho-
sphoramidite. Our route provides phosphoramidite C4 in
a10% overall yield in ten steps with eight chromatographic
puriﬁcations; in total, 0.4g of C4 was prepared in the
course of this study. We note that an alternative pathway
starting from cytidine via the N
4-acetylated, 30,50-O TIPDS
protected analog suﬀered from very poor yields during
triﬂation reactions that were required for inversion of
the conﬁguration at C20 and introduction of the methylse-
leno group. This pathway was therefore not further
continued.
Synthesis of 2’-methylseleno uridinephosphoramidite
Synthesis of the Se-modiﬁed uridine building block refers
to a previously developed route to obtain 50-O-(4,40-
dimethoxytrityl)-20-methylseleno-20-deoxyuridine phos-
phoramidite (4,27). Thereby, uridine was transformed
into 2,20-anhydro uridine; subsequent protection with
DMT at the 50-OH, followed by introduction of the
20-methylseleno group with sodium methylselenide gave
precursor U1 (Scheme 4). After release of the DMT group,
compound U2 was transformed regioselectively into the
50-O-benzhydryloxy-bis(trimethylsilyloxy)silyl protected
analog U3 by using benzhydryloxy-bis(trimethylsilyloxy)-
chlorosilane (BzHCl). Conversion into the corresponding
phosphoramidite U4 was achieved in good yields by
reaction with methyl-N,N-diisopropylchlorophosphor-
amidite. Our route provides phosphoramidite U4 in a
28% overall yield in six steps with four chromatographic
puriﬁcations. Alternatively, intermediate U3 was accessed
from 2,20-anhydro uridine U5 by direct introduction of the
O
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N
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Scheme 3. Synthesis of the 20-methylseleno cytidine phosphoramidite C4;( a) i. 1M TBAF, 0.5M acetic acid, in THF, room temperature, 18h, ii.
HCOOH, 2min, 80%; (b) 2 eq benzhydryloxy-bis(trimethylsilyloxy)chlorosilane, 3.3 eq (iPr)2NH, in CH2Cl2/DMF, room temperature, 2.5h, 54%;
(c) 1.5 eq methyl-N,N-diisopropylchlorophosphoramidite, 10 eq EtNMe2,i nC H 2Cl2, room temperature, 2h, 69%.
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Scheme 2. Synthesis of the 20-methylseleno guanosine phosphoramidite G3;( a) 2 eq benzhydryloxy-bis(trimethylsilyloxy)chlorosilane, 4 eq (iPr)2NH,
in CH2Cl2/DMF, room temperature, 2h, 46%; (b) 1.5 eq methyl-N,N-diisopropylchlorophosphoramidite, 3 eq EtNMe2,i nC H 2Cl2, room
temperature, 2h, 80%.
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introduction of the 20-methylseleno group. However, the
yields over both steps were only about 30%, therefore we
preferred the route via the tritylated derivative U1;i n
total, 0.5g of U4 was prepared in the course of this study.
Chemical synthesis of Se-containingRNA using the
ACE method
The preparation of RNA with 20-methylseleno modiﬁed
nucleosides relied on the 20-O-ACE RNA synthesis
method for strand assembly (9,19,23–25). We used an
automated solid-phase synthesizer of the type Pharmacia
Gene Assembler Plus where we bypassed the UV detection
unit to avoid damage of the ﬂow cell during treatment
with HF/TEA solution. The solid-phase synthesis cycle
was programmed according to a general description in
reference (23). An optimized protocol is provided in the
Supplementary Data available online. Therein, the cycle is
substantially changed from standard ACE RNA synthesis
by an additional step, treating the oligonucleotide chain
on the solid support with threo-1,4-dimercapto-2,
3-butanediol (DTT) after the capping–oxidation–capping
operation. With these protocols, the novel 20-methylse-
leno-modiﬁed phosphoramidites A10, C4, G3 and U4 were
successfully incorporated into oligoribonucleotides
(Figure 2, Table 1). The repeated exposure of the growing
chain to DTT is a requirement for the reliable synthesis of
RNAs (>20nt) containing multiple Se-labels and was
previously found to be advantageous for Se-containing
RNAs prepared by the 20-O-TOM approach (5,6).
Deprotection of the methyl groups from the phosphate
backbone, cleavage from the solid support and deprotec-
tion of acyl groups from 20-methylseleno-modiﬁed RNAs
were performed in the presence of DTT as well, added
in millimolar amounts to the deprotection solutions
of disodium 2-carbamoyl-2-cyanoethylene-1,1-dithiolate
trihydrate in DMF, of CH3NH2 in H2O and of the
N,N,N0,N0-tetramethylethylenediamine (TEMED) acetate
buﬀer (pH 3.8). After deprotection, DTT and other low
molecular weight components were removed by size
exclusion chromatography. RNAs were then puriﬁed by
anion-exchange chromatography under strong denatura-
ting conditions (6M urea, 808C; Figure 2). The molecular
weights of the puriﬁed RNAs were conﬁrmed by liquid
chromatography (LC) electrospray-ionization (ESI) mass
spectrometry (MS). Several oligoribonucleotides contain-
ing any of the four nucleosides with a 20-methylseleno
moiety were prepared. Their sequences S1–S11 are listed
in Table 1. Sequences S7 – S10 represent self-complemen-
tary 16nt RNAs, that contain two isolated G–A mispairs.
Crystal structures of the non-modiﬁed duplex and of a GSe
containing analog have been recently solved in coopera-
tion with A. Serganov to rationalize the inﬂuence of
20-methylseleno groups on crystallization and crystal
packing (6). Sequence S6 represents the minimal binding
motif of the tandem zinc ﬁnger domain of protein TIS11d
(28). This protein binds to the class II AU-rich element in
the 30-untranslated region of target mRNAs and promotes
their deadenylation and degradation.
Se-RNA preparation with2’-O-TOM- versus 2’-O-ACE
RNA chemistry
For reason of comparison, we synthesized the non-
modiﬁed oligoribonucleotide 50-rGCA GAG UUA AAU
CUG U-30 and the 20-methylseleno-modiﬁed analog
50-rGCASe GAG UUA AAU CUG U-30 with both, the
TOM and the ACE solid-phase synthesis methods. From
the HPLC proﬁles of the crude deprotected oligos
(Figure 3), it is obvious that the novel access for
20-methylseleno-containing RNA is of very high quality
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Scheme 4. Synthesis of the 20-methylseleno uridine phosphoramidite U4;( a) HCOOH, in CH2Cl2 (1/4 v/v), room temperature, 1h, 99%; (b)2e q
benzhydryloxy-bis(trimethylsilyloxy)chlorosilane, 3.4 eq (iPr)2NH, in CH2Cl2/DMF, room temperature, 2h, 73%; (c) 2.5 eq benzhydryloxy-
bis(trimethylsilyloxy)chlorosilane, in pyridine,  158C, 4h; (d) 6 eq NaBH4, 2 eq CH3SeSeCH3, in THF, room temperature, 2h (28% over (c) and
(d)); (e) 1.5 eq methyl-N,N-diisopropylchlorophosphoramidite, 10 eq EtNMe2,i nC H 2Cl2, room temperature, 2h, 84%.
980 Nucleic Acids Research, 2008, Vol. 36, No. 3and can compete with the established Se-TOM approach.
We note that for the Se-ACE method, complete deprotec-
tion of acyl groups and of 20-O protecting groups is much
faster (10min plus 30min) when compared to the
corresponding deprotection procedures (5h plus over-
night) required for Se-TOM chemistry. Taken together,
our goal to transfer the Se-approach to the well-reputed
ACE RNA synthesis has been satisfactorily achieved.
RNA crystallography
For X-ray structure analysis, we consider RNA with
covalent 20-methylseleno groups best applicable for sizes
up to about 80nt. Se-RNA of this dimension can be
readily obtained by solid-phase synthesis in combination
with enzymatic ligation procedures (4,29,30). For RNAs
up to about 35nt, the Se-approach is in competition with
5-iodo and 5-bromo pyrimidine derivatization (31–37).
We render the Se-approach superior since all four
20-methylseleno nucleoside phosphoramidites are avail-
able, and therefore a great ﬂexibility for adequate
positioning within the RNA target is attained. This is
important since the Se-labels should always be placed in
double helical regions of a complex fold to minimize
structural perturbance (5). In addition, 5-halogen pyrimi-
dine derivatives are highly photo-reactive species (38–40).
Inherent radiation damage of 5-halogen-modiﬁed nucleic
acids during MAD data collection has been reported as a
limitation (35). For medium-size RNA (up to 100nt), the
Se-approach competes with heavy metal ion derivatization
(41–44). Search for a suitable heavy atom is a time-
consuming process which requires soaking of the RNA
crystals with dozens of compounds at various concentra-
tions, therefore demanding many reasonably good crys-
tals. This can be a serious obstacle, as had been
encountered for the Diels–Alder ribozyme where the
Se-approach ﬁnally delivered the key derivative to
enable structure determination (16). Moreover, we have
recently shown that 20-methylseleno-modiﬁed model
duplexes gave crystals in many more buﬀer conditions
compared to their unmodiﬁed counterparts, and thus Se-
modiﬁcations hold promise to actively support the
crystallization process (6).
CONCLUSION
In the present study, we have shown that highly requested,
20-methylseleno-functionalized RNA that represents a key
derivative for RNA crystallography, is readily accessible
by the ACE synthesis protocols elaborated here.
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Figure 2. HPLC-traces of deprotected 20-methylseleno-modiﬁed RNA
(anion exchange HPLC: Dionex DNAPac (4 250mm), 808C,
1ml/min, 0–60% B in 45min; A: 25mM Tris–HCl, 6M urea, pH
8.0; B: same as A+0.5M NaClO4); (a) Crude and puriﬁed (inset)
pentamers with 20-methylseleno modiﬁcations at either A, C, G or U.
(b)2 0-Methylseleno uridine-modiﬁed A/U-rich nonamer synthesized
without (top) and with (bottom) threo-1,4-dimercapto-2,3-butanediol
(DTT) treatment during solid-phase synthesis. Both nonamers were
deprotected in the presence of DTT. (c) Non-modiﬁed nonamer as in
(b) synthesized for reason of comparison. (d) Crude 30nt RNA with
two USe labels. Deprotection procedure includes four steps: 1. 0.39M
disodium 2-carbamoyl-2-cyanoethylene-1,1-dithiolate, 150mM DTT,
DMF/H2O (13/1), 20min, room temperature; 2. 150mM DTT in
H2O, 1–3h, room temperature; 3. 40% CH3NH2 in H2O, 150mM
DTT, 10min, 608C; 4. 0.1M TEMED acetate buﬀer (pH 3.8), 150mM
DTT, 30min, 608C.
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Figure 3. Comparison of TOM versus ACE chemistry for the synthesis
of 20-methylseleno containing oligoribonucleotides, exempliﬁed by the
sequence rGCAGAGUUAAAUCUGU. HPLC-traces of crude, depro-
tected non-modiﬁed RNA (a) and of ASe-modiﬁed RNA (b); anion
exchange HPLC: Dionex DNAPac (4 250mm), 808C, 1ml/min,
0-60% B in 45min; A: 25mM Tris–HCl, 6M urea, pH 8.0; B: same
as A+0.5M NaClO4.
Nucleic Acids Research,2008, Vol. 36,No. 3 981The study further shows that the methodological transfer
to ACE-based synthesis is not only feasible but highly
satisfying since the quality of the modiﬁed Se-RNAs can
well compete with the quality of TOM-made Se-RNA.
We are convinced that this new access to 20-methylseleno
RNA will contribute to a fast dissemination of the
Se-approach for RNA X-ray structure analysis.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank the Austrian Science Fund FWF (P17864) and
the bm:bwk (Gen-AU programme; project ‘Non-coding
RNAs’ No. P7260-012-011) for funding. Dr Thomas
Mu ¨ ller (University of Innsbruck) is acknowledged for
HR ESI mass spectra. We are grateful to Dr Philipp
Hattwiger (Alnylam Europe AG, Kulmbach) for a
generous gift of ACE nucleoside building blocks.
Funding to pay the Open Access publication charges for
this article was provided by Austrian Science Fund (FWF).
Conﬂict of interest statement. None declared.
REFERENCES
1. Du,Q., Carrasco,N., Teplova,M., Wilds,C.J., Egli,M. and Huang,Z.
(2002) Internal derivatization of oligonucleotides with selenium for
X-ray crystallography using MAD. J. Am. Chem. Soc., 124, 24–25.
2. Teplova,M., Wilds,C.J., Wawrzak,Z., Tereshko,V., Du,Q.,
Carrasco,N., Huang,Z. and Egli,M. (2002) Covalent incorporation
of selenium into oligonucleotides for X-ray crystal structure
determination via MAD: proof of principle. Biochimie, 84, 849–858.
3. Pallan,P.S. and Egli,M. (2007) Selenium modiﬁcation of nucleic
acids: preparation of oligonucleotides with incorporated
20-SeMe-uridine for crystallographic phasing of nucleic acid
structures. Nat. Protocols, 2, 647–651.
4. Ho ¨ bartner,C. and Micura,R. (2004) Chemical synthesis of selenium-
modiﬁed oligoribonucleotides and their enzymatic ligation leading
to an U6 snRNA stem-loop segment. J. Am. Chem. Soc., 126,
1141–1149.
5. Ho ¨ bartner,C., Rieder,R., Kreutz,C., Puﬀer,B., Lang,K.,
Polonskaia,A., Serganov,A. and Micura,R. (2005) Syntheses of
RNAs with up to 100 nucleotides containing site-speciﬁc
20-methylseleno labels for use in X-ray crystallography. J. Am.
Chem. Soc., 127, 12035–12045.
6. Moroder,H., Kreutz,C., Lang,K., Serganov,A. and Micura,R.
(2006) Synthesis, oxidation behavior, crystallization and structure of
20-methylseleno guanosine containing RNAs. J. Am. Chem. Soc.,
128, 9909–9918.
7. Micura,R., Ho ¨ bartner,C., Rieder,R., Kreutz,C., Puﬀer,B., Lang,K.
and Moroder,H. (2006) Preparation of 20-deoxy-20-methylseleno-
modiﬁed RNA. Curr. Prot. Nucleic Acid Chem., 1, C1.15.1.–C1.15.34.
8. Pitsch,S., Weiss,P.A., Jenny,L., Stutz,A. and Wu,X. (2001)
Reliable chemical synthesis of oligoribonucleotides (RNA) with
20-O-[(triisopropyl)oxy]methyl (20-O-tom)-protected phosphorami-
dites. Helv. Chim. Acta, 84, 3773–3795.
9. Micura,R. (2002) Small interfering RNAs and their chemical
synthesis. Angew. Chem. Int. Ed. Engl., 41, 2265–2269.
10. Ho ¨ bartner,C., Kreutz,C., Flecker,E., Ottenschla ¨ ger,E., Pils,W.,
Grubmayr,K. and Micura,R. (2003) The synthesis of
20-O-[(triisopropylsilyl)-oxy]-methyl (TOM) phosphoramidites of
methylated ribonucleosides (m
1G, m
2G, m
2
2G, m
1I, m
3U, m
4C,
m
6A, m
6
2A) for use in automated RNA solid-phase synthesis.
Monatsh. Chem., 134, 851–873.
11. Ho ¨ bartner,C., Mittendorfer,H., Breuker,K. and Micura,R. (2004)
Triggering of RNA secondary structures by a functionalized
nucleobase. Angew. Chem. Int. Ed. Engl., 43, 3922–3925.
12. Kreutz,C., Ka ¨ hlig,H., Konrat,R. and Micura,R. (2006) A general
approach for the identiﬁcation of site-speciﬁc RNA binders by
19F NMR spectroscopy: proof of concept. Angew. Chem. Int. Ed.
Engl., 45, 3450–3453.
13. Ho ¨ bartner,C. and Micura,R. (2003) Bistable secondary structures of
small RNAs and their structural probing by comparative imino
proton NMR spectroscopy. J. Mol. Biol., 45, 3450–3453.
14. Serganov,A., Yuan,Y.R., Pikovskaya,O., Polonskaia,A.,
Malinina,L., Phan,A.T., Ho ¨ bartner,C., Micura,R., Breaker,R.R.
et al. (2004) Structural basis for discriminative regulation of gene
expression by adenine- and guanine-sensing mRNAs. Chem. Biol.,
11, 1729–1741.
15. Adams,P.L., Stahley,M.R., Kosek,A.B., Wang,J. and Strobel,S.A.
(2004) Crystal structure of a self-splicing group I intron with both
exons. Nature, 430, 45–50.
16. Serganov,A., Keiper,S., Malinina,L., Tereshko,V., Skripkin,E.,
Ho ¨ bartner,C., Polonskaia,A., Phan,A.T., Wombacher,R. et al.
(2005) Structural basis for Diels-Alder ribozyme-catalyzed carbon-
carbon bond formation. Nat. Struct. Mol. Biol., 12, 218–224.
17. Ennifar,E. and Dumas,P. (2006) Polymorphism of bulged-out
residues in HIV-1 RNA DIS kissing complex and
structure comparison with solution studies. J. Mol. Biol., 356,
771–782.
18. Ennifar,E., Paillart,J.C., Bodlenner,A., Walter,P., Weibel,J.M.,
Aubertin,A.M., Pale,P., Dumas,P. and Marquet,R. (2006)
Targeting the dimerization initiation site of HIV-1 RNA with
aminoglycosides: from crystal to cell. Nucleic Acids Res., 34,
2328–2339.
Table 1. RNAs with 20-methylseleno modiﬁcations prepared by ACE RNA solid-phase synthesis
a
No. Sequence
a Length Scale Isolated yield Molecular weight
(nt) (mmol) OD 260nm (nmol) (Calcd amu) Found
b (amu)
S1 50–ASeCGUA–30 5 1 10 164 1630.0 1630.3
S2 50–ACSeGUU–30 5 1 19 356 1607.0 1607.4
S3 50–ACGSeUU–30 5 1 26 472 1607.0 1607.4
S4 50–ACGUSeA–30 5 1 9 143 1630.0 1630.3
S5 50–GCGUGUSeCCG–30 9 1 13 147 2923.7 2923.5
S6 50–UUAUUUSeAUdT–30 9 2 54 547 2814.6 2815.1
S7 50–GCASeGAGUUAAAUCUGU–30 16 1 12 65 5183.1 5181.7
S8 50–GCAGAGUUAAAUCSeUGC–30 16 1 64 345 5181.1 5181.7
S9 50–GCAGSeAGUUAAAUCUGC–30 16 1 69 372 5181.1 5182.6
S10 50–GCAGAGUUSeAAAUCUGU–30 16 1 8 43 5183.1 5183.7
S11 50–A4U3USeA4UUSeUA4G4A6dA–30 30 1 49 147 9855.0 9854.4
aASe,2 0-methylseleno adenosine; CSe,2 0-methylseleno cytosine; GSe,2 0-methylseleno guanosine; USe,2 0-methylseleno uridine.
bLC-ESI MS.
982 Nucleic Acids Research, 2008, Vol. 36, No. 319. Scaringe,S.A., Wincott,F.A. and Caruthers,M.H. (1998) Novel
RNA synthesis method using 50-O-silyl-20-O-orthoester protecting
groups. J. Am. Chem. Soc., 120, 11820–11821.
20. Piton,N., Mu,Y., Stock,G., Schiemann,O., Prisner,T. and
Engels,J.W. (2007) Base-speciﬁc spin-labeling of RNA for structure
determination. Nucleic Acids Res., 35, 3128–3143.
21. Sumita,M., Desaulniers,J.-P., Chang,Y.-C., Chui,H.M.-P., Clos,L.II
and Chow,C.S. (2005) Eﬀects of nucleotide substitution and
modiﬁcation on the stability and structure of helix 69 from 28S
rRNA. RNA, 11, 1420–1429.
22. Desaulniers,J.-P., Chui,H.M.-P. and Chow,C.S. (2005) Solution
conformations of two naturally occurring RNA nucleosides:
3-methyluridine and 3-methylpseudouridine. Bioorg. Med. Chem.,
13, 6777–6781.
23. Scaringe,S.A. (2000) Advanced 50-silyl-20-orthoester approach to
RNA oligonucleotide synthesis. Methods Enzymol., 317, 3–18.
24. Scaringe,S.A. (2001) RNA oligonucleotide synthesis via 50-silyl-
20-orthoester chemistry. Methods, 23, 206–217.
25. Hartsel,S.A., Kitchen,D.E., Scaringe,S.A. and Marshall,W.S. (2005)
RNA oligonucleotide synthesis via 50-silyl-20-orthoester chemistry.
Methods Mol. Biol., 288, 33–50.
26. Bain,J.D., Wacker,D.A., Kuo,E.E., Lyttle,M.H. and
Chamberlin,A.R. (1991) Preparation of chemically misacylated
semisynthetic nonsense suppressor tRNAs employed in biosynthetic
incorporation of non-natural residues into proteins. J. Org. Chem.,
56, 4615–4625.
27. Salon,Z., Chen,G., Portilla,Y., Germann,M.W. and Huang,Z.
(2005) Synthesis of a 20-Se-uridine phosphoramidite and its
incorporation into oligonucleotides for structural study. Org. Lett.,
7, 5645–5648.
28. Hudson,B.P., Martinez-Yamout,M.A., Dyson,H.J. and Wright,P.E.
(2004) Recognition of the mRNA AU-rich element by the zinc
ﬁnger domain of TIS11d. Nat. Struct. Mol. Biol., 11, 257–264.
29. Rieder,R., Lang,K., Graber,D. and Micura,R. (2007) Ligand-
induced folding of the adenosine deaminase A-riboswitch and
implications on riboswitch translational control. Chembiochem., 8,
896–902.
30. Lang,K., Rieder,R. and Micura,R. (2007) Ligand-induced folding
of the thiM TPP riboswitch investigated by a structure-based
ﬂuorescence spectroscopic approach. Nucleic Acids Res., 35,
5370–5378.
31. Shui,X., Peek,M.E., Lipscomb,L.A., Gao,Q., Ogata,C.,
Roques,B.P., Garbay-Jaureguiberry,C., Wilkinson,A.P. and
Williams,I.D. (2000) Eﬀects of cationic charge on three-dimensional
structures of intercalative complexes: structure of a bis-
intercalated DNA complex solved by MAD phasing. Curr. Med.
Chem., 7, 59–71.
32. Deng,J., Xiong,Y. and Sundaralingam,M. (2001) X-ray analysis of
an RNA tetraplex (UGGGGU)4 with divalent Sr
2+ ions at
subatomic resolution (0.61A ˚ ). Proc. Natl Acad. Sci. USA, 98,
13665–13670.
33. Wing,R., Drew,H., Takano,T., Broka,C., Tanaka,S., Itakura,K.
and Dickerson,R.E. (1980) Crystal structure analysis of a complete
turn of B-DNA. Nature, 287, 755–758.
34. Zhang,L. and Doudna,J.A. (2002) Structural insights into group II
intron catalysis and branch-site selection. Science, 295, 2084–2088.
35. Ennifar,E., Carpentier,P., Ferrer,J.L., Walter,P. and Dumas,P.
(2002) X-ray-induced debromination of nucleic acids at the Br K
absorption edge and implications for MAD phasing. Acta
Crystallogr. D Biol. Crystallogr., 58, 1262–1268.
36. Nowakowski,J., Shim,P.J., Stout,D. and Joyce,G.F. (2000)
Alternative conformations of a nucleic acid four-way junction.
J. Mol. Biol., 300, 93–102.
37. Correll,C.C., Freeborn,B., Moore,P.B. and Steitz,T.A. (1997)
Metals, motifs, and recognition in the crystal structure of a 5S
rRNA domain. Cell, 91, 705–712.
38. Gott,J.M., Wu,H., Koch,T.H. and Uhlenbeck,O.C. (1991) A
speciﬁc, UV-induced RNA-protein cross-link using 5-bromouridine-
substituted RNA. Biochemistry, 30, 6290–6295.
39. Xu,Y. and Sugiyama,H. (2004) Highly eﬃcient photochemical
20-deoxyribonolactone formation at the diagonal loop of a
5-iodouracil-containing antiparallel G-quartet. J. Am. Chem. Soc.,
126, 6274–6279.
40. Zeng,Y. and Wang,Y. (2004) Facile formation of an intrastrand
cross-link lesion between cytosine and guanine upon pyrex-ﬁltered
UV light irradiation of d((Br)CG) and duplex DNA containing
5-bromocytosine. J. Am. Chem. Soc., 126, 6552–6553.
41. Golden,B.L. (2000) Heavy atom derivatives of RNA. Methods
Enzymol., 317, 124–132.
42. Ennifar,E., Walter,P. and Dumas,P. (2001) An eﬃcient method for
solving RNA structures: MAD phasing by replacing magnesium
with zinc. Acta Cryst. D Biol. Crystallogr., 57, 330–332.
43. Francois,B., Lescoute-Phillips,A., Werner,A. and Masquida,B.
(2005) Preparation and handling of RNA crystals.
In Hartmann,R.K., Bindereif,A., Scho ¨ n,A. and Westhof,E. (eds),
Handbook of RNA Biochemistry, Wiley-VCH, pp. 438–452.
44. Ke,A. and Doudna,J.A. (2004) Crystallization of RNA and RNA-
protein complexes. Methods, 34, 408–414.
Nucleic Acids Research,2008, Vol. 36,No. 3 983